Australija - engleski - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - potassium clavulanate, quantity: 148.875 mg; amoxicillin trihydrate, quantity: 575 mg - tablet, film coated - excipient ingredients: propylene glycol; dichloromethane; hypromellose; magnesium stearate; croscarmellose sodium; ethylcellulose; purified talc; isopropyl alcohol; microcrystalline cellulose; titanium dioxide; hyprolose; industrial methylated spirit - medreich co-amoxiclav 500/125 and medreich co-amoxiclav 875/125 tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (uncomplicated and complicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infection,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate.,the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets should not require the addition of another antibiotic due to the amoxicillin content of these products.

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - potassium clavulanate; amoxicillin trihydrate - oral tablet - 125mg ; 250mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - amoxicillin sodium; potassium clavulanate - powder for solution for injection - 500mg ; 100mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - amoxicillin sodium; potassium clavulanate - powder for solution for injection - 1000mg ; 200mg

Irska - engleski - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - amoxicillin sodium; clavulanic acid (in the form of potassium clavulanate) - powder for solution for injection/infusion - 1000/200 milligram(s) - combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - potassium clavulanate; amoxicillin trihydrate - oral suspension - 6.25mg/1ml ; 25mg/1ml

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - amoxicillin trihydrate; potassium clavulanate - oral suspension - 50mg/1ml ; 12.5mg/1ml

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - amoxicillin trihydrate; potassium clavulanate - oral suspension - 80mg/1ml ; 11.4mg/1ml